# Pharming Group N.V.: Form 20-F for the period ended Dec 31, 2020

- Company: [Pharming Group N.V.](/companies/phar.md) (CIK 1828316)
- Form: 20-F
- Filed: 2021-04-07
- Accepted by EDGAR: Apr 7, 2021, 16:22 ET
- Period: 2020-12-31
- Accession: 0001628280-21-006652
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1828316/000162828021006652/pharm-20201231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1828316/000162828021006652/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Shares outstanding | at 2020-12-31 | 638,821,619 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1828316/000162828021006652/pharm-20201231.htm

Filed Apr 7, 2021.
Source: SEC EDGAR, the filing index for accession 0001628280-21-006652. Last ingested by Listed: Nov 6, 2026, 11:08 ET. No prices; not investment advice.
